Reviewed by Michael Gill, B. Sc.
4 Pituitary Tumor Clinical Trials Near Me
Top Hospitals for Pituitary Tumor Clinical Trials
Image of Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities) in New Jersey.
Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge
1Active Trials
1All Time Trials for Pituitary Tumor
2019First Pituitary Tumor Trial
Image of Memoral Sloan Kettering Monmouth (Limited Protocol Activities) in New Jersey.
Memoral Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown
1Active Trials
1All Time Trials for Pituitary Tumor
2019First Pituitary Tumor Trial
Top Cities for Pituitary Tumor Clinical Trials
Image of New York in New York.
New York
2Active Trials
Memorial Sloan - Kettering Cancer Center (All Protocol Activities)Top Active Site
Image of Los Angeles in California.
Los Angeles
2Active Trials
Cedars-Sinai Medical CenterTop Active Site
Pituitary Tumor Clinical Trials by Phase of Trial
Phase 2 Pituitary Tumor Clinical Trials
1Active Pituitary Tumor Clinical Trials
1Number of Unique Treatments
8Number of Active Locations
Pituitary Tumor Clinical Trials by Age Group
18+ Pituitary Tumor Clinical Trials
4Active Pituitary Tumor Clinical Trials
Most Recent Pituitary Tumor Clinical Trials
Top Treatments for Pituitary Tumor Clinical Trials
Treatment Name
Active Pituitary Tumor Clinical Trials
All Time Trials for Pituitary Tumor
First Recorded Pituitary Tumor Trial
Nivolumab
1
1
2019
No nasal packing.
1
1
2019
Fluid Restricted Group
1
1
2016
Pasireotide
1
2
2010

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 5th, 2021

Last Reviewed: October 3rd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Dai C, Liang S, Sun B, Kang J. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas. Front Endocrinol (Lausanne). 2020 Dec 11;11:608422. doi: 10.3389/fendo.2020.608422. eCollection 2020. Review. https://pubmed.ncbi.nlm.nih.gov/33362722